Galapagos NV - ADR is a global biotechnology firm committed to developing novel medicines with transformative potential in immunology, oncology and other indications.
Operating within the robust biopharmaceutical industry, Galapagos NV is engaged in integrated drug discovery, leveraging proprietary novel compounds that offer promising therapeutic applications. Galapagos NV partnered with Gilead to work on the development and commercialization of Filgotinib which is used for rheumatoid arthritis and ulcerative colitis.
Elevate your trading game by tracking the share price of GLPG by adding it to your eToro watchlist.